This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Hong Kong, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, country managers of the world’s leading biopharmaceutical companies, representatives from local SMEs and service providers, and the leading figures from Hong Kong’s rich network of research and educational institutes.
Opinion / How Can the Generics Industry Up its Game on Essential Medicine Access?
Claudia Martínez, generic & biosimilar medicines programme manager at the Access to Medicine Foundation, draws from a recent AMF report to outline what more generics companies can be doing to…
